lenercept
Recombinant proteinexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- TNF-alphaINHIBITOR
TNF inhibitor
Gene fusion of the extracellular portion of human type 1 TNFR with the constant domains of human IgG heavy chain (TNFR-IgG).
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2108208 ↗
Also known as
- lenercept
- lenercept
- p55-igg
- ro 45-2081
- ro-452081
- ro-45-2081
- tenefuse
- tnfr-igg